{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T02:24:18Z","timestamp":1768616658448,"version":"3.49.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HD071920-0"],"award-info":[{"award-number":["R01 HD071920-0"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.contraception.2021.04.009","type":"journal-article","created":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T16:34:23Z","timestamp":1619109263000},"page":"29-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["The burden of the Risk Evaluation and Mitigation Strategy (REMS) on providers and patients experiencing early pregnancy loss: A commentary"],"prefix":"10.1016","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4809-3595","authenticated-orcid":false,"given":"Anne N.","family":"Flynn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6546-6835","authenticated-orcid":false,"given":"Jade M.","family":"Shorter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea H.","family":"Roe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarita","family":"Sonalkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Courtney A.","family":"Schreiber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2021.04.009_bib0001","first-page":"1","article-title":"Spontaneous abortion risks in man: data from reproductive histories collected in a medical genetics unit","volume":"16","author":"Warburton","year":"1964","journal-title":"Am J Hum Genet"},{"issue":"7","key":"10.1016\/j.contraception.2021.04.009_bib0002","first-page":"1","article-title":"Estimated pregnancy rates and rates of pregnancy outcomes for the United States, 1990-2008","volume":"60","author":"Ventura","year":"2012","journal-title":"Natl Vital Stat Rep"},{"issue":"8","key":"10.1016\/j.contraception.2021.04.009_bib0003","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1056\/NEJMoa044064","article-title":"A comparison of medical management with misoprostol and surgical management for early pregnancy failure","volume":"353","author":"Zhang","year":"2005","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.contraception.2021.04.009_bib0004","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijgo.2007.04.031","article-title":"Clinical indicators for success of misoprostol treatment after early pregnancy failure","volume":"99","author":"Robledo","year":"2007","journal-title":"Int J Gynaecol Obstet"},{"issue":"6","key":"10.1016\/j.contraception.2021.04.009_bib0005","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.contraception.2006.07.007","article-title":"Mifepristone and misoprostol for the treatment of early pregnancy failure: a pilot clinical trial","volume":"74","author":"Schreiber","year":"2006","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.contraception.2021.04.009_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2010.12.026","article-title":"Mifepristone and misoprostol for early pregnancy failure: a cohort analysis","volume":"204","author":"Kollitz","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.contraception.2021.04.009_bib0007","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1097\/AOG.0000000000001753","article-title":"Treatment decisions at the time of miscarriage diagnosis","volume":"128","author":"Schreiber","year":"2016","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.contraception.2021.04.009_bib0008","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1097\/AOG.0000000000002900","article-title":"Practice Bulletin No. 200 summary: early pregnancy loss","volume":"132","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2021.04.009_bib0009","article-title":"Medical treatment for early fetal death (less than 24 weeks)","volume":"6","author":"Lemmers","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.contraception.2021.04.009_bib0010","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/humupd\/dmz002","article-title":"Management of first-trimester miscarriage: a systematic review and network meta-analysis","volume":"25","author":"Wattar","year":"2019","journal-title":"Hum Reprod Update"},{"issue":"10253","key":"10.1016\/j.contraception.2021.04.009_bib0011","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/S0140-6736(20)31788-8","article-title":"Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso): a randomised, double-blind, placebo-controlled trial","volume":"396","author":"Chu","year":"2020","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.contraception.2021.04.009_bib0012","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1056\/NEJMoa1715726","article-title":"Mifepristone pretreatment for the medical management of early pregnancy loss","volume":"378","author":"Schreiber","year":"2018","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.contraception.2021.04.009_bib0013","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.1594","article-title":"Cost-effectiveness of mifepristone pretreatment for the medical management of nonviable early pregnancy: secondary analysis of a randomized clinical trial","volume":"3","author":"Nagendra","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.contraception.2021.04.009_bib0014","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1097\/AOG.0000000000004063","article-title":"Mifepristone combination therapy compared with misoprostol monotherapy for the management of miscarriage: a cost-effectiveness analysis","volume":"136","author":"Berkley","year":"2020","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.contraception.2021.04.009_bib0015","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1080\/13625187.2020.1743825","article-title":"Slow implementation of mifepristone medical termination of pregnancy in Quebec, Canada: a qualitative investigation","volume":"25","author":"Guilbert","year":"2020","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"5894","key":"10.1016\/j.contraception.2021.04.009_bib0016","first-page":"1298","article-title":"Life cycle of translational research for medical interventions","volume":"321","author":"Contopoulos-Ioannidis","year":"2008","journal-title":"Medicine"},{"issue":"7","key":"10.1016\/j.contraception.2021.04.009_bib0017","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1056\/NEJMp1908305","article-title":"Time to reevaluate U.S. mifepristone restrictions","volume":"381","author":"Henney","year":"2019","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.contraception.2021.04.009_bib0018","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.contraception.2015.06.016","article-title":"Aligning mifepristone regulation with evidence: driving policy change using 15 years of excellent safety data","volume":"92","author":"Cleland","year":"2015","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2021.04.009_bib0019","unstructured":"ACOG. Improving access to mifepristone for reproductive health indications. 2018; Posiiton Statement]."},{"issue":"5","key":"10.1016\/j.contraception.2021.04.009_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2007.11.011","article-title":"United States emergency department visits for vaginal bleeding during early pregnancy, 1993-2003","volume":"198","author":"Wittels","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.contraception.2021.04.009_bib0021","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1097\/AOG.0000000000003571","article-title":"Patient experiences with miscarriage management in the emergency and ambulatory settings","volume":"134","author":"Miller","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2021.04.009_bib0022","article-title":"Ethnicity and clinical outcomes in COVID-19: A systematic review and meta-analysis","volume":"29","author":"Sze","year":"2020","journal-title":"EClinicalMedicine"},{"issue":"9","key":"10.1016\/j.contraception.2021.04.009_bib0023","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003379","article-title":"Patterns of COVID-19 testing and mortality by race and ethnicity among United States veterans: a nationwide cohort study","volume":"17","author":"Rentsch","year":"2020","journal-title":"PLoS Med"},{"key":"10.1016\/j.contraception.2021.04.009_bib0024","unstructured":"FDA, Guidance for Industry and Health Care Professionals: Policy for Certain REMS requirements during the COVID-19 Public Health Emergency. https:\/\/www.fda.gov\/media\/136317\/download."},{"key":"10.1016\/j.contraception.2021.04.009_bib0025","unstructured":"ACLU, Federal court blocks FDA restsriction that unnecessarily imposes COVID-19 risks on patients seeking abortion care 2020: https:\/\/www.aclu.org\/press-releases\/federal-court-blocks-fda-restriction-unnecessarily-imposes-covid-19-risks-patients#:~:text=The%20court%20issued%20a%20preliminary,as%20part%20of%20miscarriage%20treatment."},{"key":"10.1016\/j.contraception.2021.04.009_bib0026","series-title":"Supreme Court Revives Abortion-Pill Restriction","author":"Liptak","year":"2021"},{"key":"10.1016\/j.contraception.2021.04.009_bib0028","unstructured":"Belluck, P., F.D.A. Will Allow Abortion Pills by Mail During the Pandemic, in The New York Times. 2021."},{"key":"10.1016\/j.contraception.2021.04.009_bib0027","unstructured":"Berry, C.R. The dividing line between the role of the FDA and the practice of medicine: a historical review and current analysis. 1997. http:\/\/nrs.harvard.edu\/urn-3:HUL.InstRepos:8846812"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782421001141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782421001141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T20:18:56Z","timestamp":1757881136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782421001141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0010782421001141"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2021.04.009","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The burden of the Risk Evaluation and Mitigation Strategy (REMS) on providers and patients experiencing early pregnancy loss: A commentary","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2021.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}